1. Home
  2. HCWB vs PT Comparison

HCWB vs PT Comparison

Compare HCWB & PT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCWB
  • PT
  • Stock Information
  • Founded
  • HCWB 2018
  • PT 2012
  • Country
  • HCWB United States
  • PT China
  • Employees
  • HCWB N/A
  • PT N/A
  • Industry
  • HCWB Biotechnology: Pharmaceutical Preparations
  • PT Computer Software: Programming Data Processing
  • Sector
  • HCWB Health Care
  • PT Technology
  • Exchange
  • HCWB Nasdaq
  • PT Nasdaq
  • Market Cap
  • HCWB 16.1M
  • PT 15.2M
  • IPO Year
  • HCWB 2021
  • PT 2018
  • Fundamental
  • Price
  • HCWB $3.79
  • PT $0.93
  • Analyst Decision
  • HCWB Strong Buy
  • PT
  • Analyst Count
  • HCWB 1
  • PT 0
  • Target Price
  • HCWB $35.00
  • PT N/A
  • AVG Volume (30 Days)
  • HCWB 235.7K
  • PT 14.7K
  • Earning Date
  • HCWB 08-13-2025
  • PT 07-07-2025
  • Dividend Yield
  • HCWB N/A
  • PT N/A
  • EPS Growth
  • HCWB N/A
  • PT N/A
  • EPS
  • HCWB N/A
  • PT N/A
  • Revenue
  • HCWB $1,445,145.00
  • PT $4,814,566.00
  • Revenue This Year
  • HCWB N/A
  • PT N/A
  • Revenue Next Year
  • HCWB N/A
  • PT N/A
  • P/E Ratio
  • HCWB N/A
  • PT N/A
  • Revenue Growth
  • HCWB N/A
  • PT N/A
  • 52 Week Low
  • HCWB $3.55
  • PT $0.76
  • 52 Week High
  • HCWB $100.80
  • PT $1.15
  • Technical
  • Relative Strength Index (RSI)
  • HCWB 30.10
  • PT 46.61
  • Support Level
  • HCWB $3.55
  • PT $0.89
  • Resistance Level
  • HCWB $5.47
  • PT $0.95
  • Average True Range (ATR)
  • HCWB 0.57
  • PT 0.06
  • MACD
  • HCWB -0.03
  • PT 0.00
  • Stochastic Oscillator
  • HCWB 20.81
  • PT 57.21

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.

About PT Pintec Technology Holdings Limited

Pintec Technology Holdings Ltd is a technology platform that provides financial services in China in terms of loan volume facilitated. The company connects business partners and financial partners on its open platform and enables them to provide financial services to end-users. Its products include installment loans, personal loans, wealth management, insurance brokerage, SME loans, and others. The company generates its revenue from technical service fees, as well as by providing financing for these borrowers and earning installment service fees. The company earns wealth management services fees and commissions on financial products. The company generates the majority of its revenue from Wealth management service fees and others.

Share on Social Networks: